System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Hisao Asamura is an expert in Oncology at Tokyo Dental College Ichikawa General Hospital (Japan). As of June 2026, ScienceLeadR ranks Hisao Asamura in the top 1% of experts worldwide for Thoracic Neoplasms, Lung Neoplasms and Bronchial Neoplasms. Hisao Asamura has authored 485 publications, the most recent in 2026. SLR score: 1,530 (community average: 125). How the SLR is computed.

LeadR Profile

Hisao Asamura Tokyo Dental College Ichikawa General Hospital Japan
1 530 ScienceLeadR Reputation 1530

Unlock

Register Login
Network Map

Oncology

Subspecialties: Pulmonology - Surgery - Thoracic And Cardiovascular Surgery

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1989 - 2026
Source: PubMed

Keio University

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 485

Citations

Citations: 39 997 1st author: 37 Last author: 84 Unique author: 33

Main journals

J Thorac Oncol 143
Ann Thorac Surg 31
Lung Cancer 30
Jpn J Clin Oncol 27
J Thorac Cardiovasc Surg 19

Best Journals

J Clin Oncol 3
Ann Oncol 2
CA Cancer J Clin 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
The 9th Edition of the UICC TNM Classification of Malignant Tumours: Updates and Rationale for Change.
PMID 42261202 — neoplasms, classification, lung neoplasms		Int J Cancer20261
Segmentectomy versus lobectomy in non-small-cell lung cancer with pathologically invasive features: a post-hoc supplementary analysis of a multicenter, Phase 3 trial JCOG0802/WJOG4607L.
PMID 42119729 — cells, lung, incidence, neoplasms, carcinoma, non-small-cell lung, mastectomy, segmental, lung neoplasms, lymph, small cell lung carcinoma		J Thorac Oncol20260
Five-year overall survival in JCOG1205/1206: irinotecan or etoposide plus cisplatin for resected high-grade neuroendocrine carcinoma of the lung.
PMID 42000139 — lung, drug therapy, lung neoplasms, chemotherapy, adjuvant, etoposide, irinotecan, carcinoma, neuroendocrine, chemotherapy		Lung Cancer20260
Corrigendum to "The International Association for the Study of Lung Cancer Staging Project: The Impact of Common Molecular Alterations on Overall Survival in NSCLC in Initial Analyses of the IASLC Ninth Edition Staging Database. [Journal of Thoracic Oncology Vol. 20 No. 10: 1423-1440]".
PMID 41175134 — lung, neoplasms, neoplasm staging, carcinoma, non-small-cell lung, lung neoplasms		J Thorac Oncol20250
The International Association for the Study of Lung Cancer Staging Project: The Impact of Common Molecular Alterations on Overall Survival in NSCLC in Initial Analyses of the IASLC Ninth Edition Staging Database.
PMID 40920144 — lung, neoplasms, neoplasm staging, carcinoma, non-small-cell lung, lung neoplasms, mutation		J Thorac Oncol20251

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS